M&G Investment Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

M&G Investment Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-356,454	Closed	-$356	–	497
2020 Q4	$356	Hold	356,454	–	–	﹤0.01%	378
2020 Q3	$713K	Sell	356,454 -11,749	-3%	-$33.6K	0.01%	323
2020 Q2	$1.47M	Hold	368,203	–	–	0.02%	276
2020 Q1	$1.47M	Hold	368,203	–	–	0.02%	263
2019 Q4	$1.1M	Buy	+368,203	New	+$957K	0.01%	325

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

M&G Investment Management's BMY.RT Position: Q1 2021 in Review

M&G Investment Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 356,454 shares — an estimated $356 sold.

M&G Investment Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1.47M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

M&G Investment Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
M&G Investment Management sold 356,454 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $356.
M&G Investment Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
M&G Investment Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.47M in Q2 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on M&G Investment Management's 13F filing for Q1 2021, filed 12 May 2021.